1.Suqian Nursing School of Jiangsu Province,Suqian 223800,Chna;
2.Department of Infection,Zhongwu Hospital of Suqian City,Jiangsu Province,Suqian 223800,China
Abstract：ObjectiveTo investigate the clinical effect of Fuzheng Huayu Capsules combined with Entecavir in the treatment of liver cirrhosis of hepatitis B.MethodsFrom January 2013 to December 2016,120 patients with liver cirrhosis of hepatitis B treated in Zhongwu Hospital of Suqian City were selected and they were divided into the observation group(n=60)and control group(n=60)in random.The Compound Glycyrrhizin,Reduced Glutathione,liver protection,and enzyme decrease were provided in both groups.In the control group,oral administration of Entecavir Dispersible Tablets was applied,0.5 mg each time,once a day.In the observation group,Fuzheng Huayu Capsules for oral administration was adopted,0.2 g each time,3 times per day.Alanine transaminase(ALT),aspartate aminotransferase(AST),albumin(Alb),total bilirubin(TBil),Child-Pugh score,HBV-DNA quantitative,laminin(LN),Ⅳ-collagen(Ⅳ-C),hyaluronic acid(HA),mean flow velocity of main portal vein(v),and internal diameter of portal vein(D)were compared and observed in the two groups before and after 6 months treatment.ResultsAfter treatment,ALT,AST,Alb,TBil,LN,Ⅳ-C,HA,Child-Push score,and HBV-DNA quantitative were significantly better than those before treatment(P＜0.05).Alb,Child-Pugh score,LN,Ⅳ-C,and HA in the observation group were all better than those in the control group after therapy(P＜0.05).There was no great difference in improvement of mean flow velocity of main portal vein(v),and internal diameter of portal vein(D)in the control group compared with that before(P＞0.05).In the observation group,the improvement of mean flow velocity of main portal vein(v)was better than that before with a statistical difference.Meanwhile,internal diameter of portal vein(D)in the observation group after therapy was greatly improved but without statistical significance(P＞0.05).ConclusionEntecavir treating liver cirrhosis of hepatitis B can swiftly inhibit viral replication and decrease the amount of hepatitis B virus in peripheral blood,and restore the liver function to normal.Entecavir combined with Fuzheng Huayu Capsules can reduce Child-Pugh score,increase Alb level,and improve liver fibrosis indexes and portal vein hemodynamics.
张生玉；周付成；牛玉兰；吴倩. 扶正化瘀胶囊联合恩替卡韦治疗乙肝肝硬化的临床效果[J]. 中国当代医药, 2017, 24(35): 147-149转152.
ZHANG Sheng-yu；ZHOU Fu-cheng；NIU Yu-lan；WU Qian. Clinical effect of Fuzheng Huayu Capsules combined with Entecavir in the treatment of liver cirrhosis of hepatitis B. 中国当代医药, 2017, 24(35): 147-149转152.
Liang X，Bi S，Yang W，et al.Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination[J].Vaccine，2009，27（47）:6550-6557.
京公网安备 11010502046607号